CG
QTTB icon

Cutler Group’s Q32 Bio QTTB Stock Holding History

Cutler Group’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-44
Closed -$1K – 6430
2020
Q4 		$1K Buy
+44
New +$8.51K ﹤0.01% 4631
2020
Q3 		– Sell
-167
Closed -$3K – 5349
2020
Q2 		$3K Buy
+167
New +$44.5K ﹤0.01% 3681
2020
Q1 		– Sell
-22
Closed -$1K – 4788
2019
Q4 		$1K Buy
+22
New +$6.3K ﹤0.01% 3814

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's QTTB Position: Q4 2021 in Review

Cutler Group sold out of Q32 Bio (QTTB) in Q4 2021, closing a stake of 50 shares — an estimated $7K sold.

Cutler Group first reported a position in QTTB in Q4 2019 and held it in 7 quarters. The position peaked at $28K in Q4 2020. 120 funds tracked by Wall St. Rank hold QTTB as of Q4 2021.

  • Cutler Group reported no remaining Q32 Bio position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 50 Q32 Bio shares in Q4 2021, an estimated $7K.
  • Cutler Group first reported a position in Q32 Bio in Q4 2019 and held it in 7 quarters.
  • Cutler Group's Q32 Bio position peaked at $28K in Q4 2020.
  • 120 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.